Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
This report contains market size and forecasts of Oncology Drugs in Global, including the following market information:
Global Oncology Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oncology Drugs market was valued at 203160 million in 2021 and is projected to reach US$ 392310 million by 2028, at a CAGR of 9.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oncology Drugs include Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oncology Drugs Market Segment Percentages, by Type, 2021 (%)
- Chemotherapy
- Targeted Therapy
- Immunotherapy (Biologic Therapy)
- Hormonal Therapy
- Others
Global Oncology Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oncology Drugs Market Segment Percentages, by Application, 2021 (%)
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory or Lung Cancer
- Others
Global Oncology Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oncology Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oncology Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Celgene
- Novartis
- Bristol-Myers Squibb
- Johnson & Johnson
- Merck & Co.
- AstraZeneca
- Pfizer
- Amgen
- Eli Lilly
- AbbVie
- Takeda
- Astellas
- Ipsen
- Sanofi
- Bayer
- Biogen Idec
- Teva
- Otsuka
- Eisai
- Merck KGaA
- Gilead Sciences
Oncology Drugs Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Oncology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Drugs Overall Market Size
2.1 Global Oncology Drugs Market Size: 2021 VS 2028
2.2 Global Oncology Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Drugs Players in Global Market
3.2 Top Global Oncology Drugs Companies Ranked by Revenue
3.3 Global Oncology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Oncology Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oncology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Oncology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Oncology Drugs Market Size Markets, 2021 & 2028
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Immunotherapy (Biologic Therapy)
4.1.5 Hormonal Therapy
4.1.6 Others
4.2 By Type - Global Oncology Drugs Revenue & Forecasts
4.2.1 By Type - Global Oncology Drugs Revenue, 2017-2022
4.2.2 By Type - Global Oncology Drugs Revenue, 2023-2028
4.2.3 By Type - Global Oncology Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Drugs Market Size, 2021 & 2028
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory or Lung Cancer
5.1.7 Others
5.2 By Application - Global Oncology Drugs Revenue & Forecasts
5.2.1 By Application - Global Oncology Drugs Revenue, 2017-2022
5.2.2 By Application - Global Oncology Drugs Revenue, 2023-2028
5.2.3 By Application - Global Oncology Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Oncology Drugs Market Size, 2021 & 2028
6.2 By Region - Global Oncology Drugs Revenue & Forecasts
6.2.1 By Region - Global Oncology Drugs Revenue, 2017-2022
6.2.2 By Region - Global Oncology Drugs Revenue, 2023-2028
6.2.3 By Region - Global Oncology Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Oncology Drugs Revenue, 2017-2028
6.3.2 US Oncology Drugs Market Size, 2017-2028
6.3.3 Canada Oncology Drugs Market Size, 2017-2028
6.3.4 Mexico Oncology Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Oncology Drugs Revenue, 2017-2028
6.4.2 Germany Oncology Drugs Market Size, 2017-2028
6.4.3 France Oncology Drugs Market Size, 2017-2028
6.4.4 U.K. Oncology Drugs Market Size, 2017-2028
6.4.5 Italy Oncology Drugs Market Size, 2017-2028
6.4.6 Russia Oncology Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Oncology Drugs Market Size, 2017-2028
6.4.8 Benelux Oncology Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Oncology Drugs Revenue, 2017-2028
6.5.2 China Oncology Drugs Market Size, 2017-2028
6.5.3 Japan Oncology Drugs Market Size, 2017-2028
6.5.4 South Korea Oncology Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Oncology Drugs Market Size, 2017-2028
6.5.6 India Oncology Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Oncology Drugs Revenue, 2017-2028
6.6.2 Brazil Oncology Drugs Market Size, 2017-2028
6.6.3 Argentina Oncology Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Drugs Revenue, 2017-2028
6.7.2 Turkey Oncology Drugs Market Size, 2017-2028
6.7.3 Israel Oncology Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Oncology Drugs Market Size, 2017-2028
6.7.5 UAE Oncology Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Oncology Drugs Major Product Offerings
7.1.4 Roche Oncology Drugs Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Celgene
7.2.1 Celgene Corporate Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Oncology Drugs Major Product Offerings
7.2.4 Celgene Oncology Drugs Revenue in Global Market (2017-2022)
7.2.5 Celgene Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Oncology Drugs Major Product Offerings
7.3.4 Novartis Oncology Drugs Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Oncology Drugs Major Product Offerings
7.4.4 Bristol-Myers Squibb Oncology Drugs Revenue in Global Market (2017-2022)
7.4.5 Bristol-Myers Squibb Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Oncology Drugs Major Product Offerings
7.5.4 Johnson & Johnson Oncology Drugs Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Merck & Co.
7.6.1 Merck & Co. Corporate Summary
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Oncology Drugs Major Product Offerings
7.6.4 Merck & Co. Oncology Drugs Revenue in Global Market (2017-2022)
7.6.5 Merck & Co. Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Oncology Drugs Major Product Offerings
7.7.4 AstraZeneca Oncology Drugs Revenue in Global Market (2017-2022)
7.7.5 AstraZeneca Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oncology Drugs Major Product Offerings
7.8.4 Pfizer Oncology Drugs Revenue in Global Market (2017-2022)
7.8.5 Pfizer Key News
7.9 Amgen
7.9.1 Amgen Corporate Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Oncology Drugs Major Product Offerings
7.9.4 Amgen Oncology Drugs Revenue in Global Market (2017-2022)
7.9.5 Amgen Key News
7.10 Eli Lilly
7.10.1 Eli Lilly Corporate Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Oncology Drugs Major Product Offerings
7.10.4 Eli Lilly Oncology Drugs Revenue in Global Market (2017-2022)
7.10.5 Eli Lilly Key News
7.11 AbbVie
7.11.1 AbbVie Corporate Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Oncology Drugs Major Product Offerings
7.11.4 AbbVie Oncology Drugs Revenue in Global Market (2017-2022)
7.11.5 AbbVie Key News
7.12 Takeda
7.12.1 Takeda Corporate Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Oncology Drugs Major Product Offerings
7.12.4 Takeda Oncology Drugs Revenue in Global Market (2017-2022)
7.12.5 Takeda Key News
7.13 Astellas
7.13.1 Astellas Corporate Summary
7.13.2 Astellas Business Overview
7.13.3 Astellas Oncology Drugs Major Product Offerings
7.13.4 Astellas Oncology Drugs Revenue in Global Market (2017-2022)
7.13.5 Astellas Key News
7.14 Ipsen
7.14.1 Ipsen Corporate Summary
7.14.2 Ipsen Business Overview
7.14.3 Ipsen Oncology Drugs Major Product Offerings
7.14.4 Ipsen Oncology Drugs Revenue in Global Market (2017-2022)
7.14.5 Ipsen Key News
7.15 Sanofi
7.15.1 Sanofi Corporate Summary
7.15.2 Sanofi Business Overview
7.15.3 Sanofi Oncology Drugs Major Product Offerings
7.15.4 Sanofi Oncology Drugs Revenue in Global Market (2017-2022)
7.15.5 Sanofi Key News
7.16 Bayer
7.16.1 Bayer Corporate Summary
7.16.2 Bayer Business Overview
7.16.3 Bayer Oncology Drugs Major Product Offerings
7.16.4 Bayer Oncology Drugs Revenue in Global Market (2017-2022)
7.16.5 Bayer Key News
7.17 Biogen Idec
7.17.1 Biogen Idec Corporate Summary
7.17.2 Biogen Idec Business Overview
7.17.3 Biogen Idec Oncology Drugs Major Product Offerings
7.17.4 Biogen Idec Oncology Drugs Revenue in Global Market (2017-2022)
7.17.5 Biogen Idec Key News
7.18 Teva
7.18.1 Teva Corporate Summary
7.18.2 Teva Business Overview
7.18.3 Teva Oncology Drugs Major Product Offerings
7.18.4 Teva Oncology Drugs Revenue in Global Market (2017-2022)
7.18.5 Teva Key News
7.19 Otsuka
7.19.1 Otsuka Corporate Summary
7.19.2 Otsuka Business Overview
7.19.3 Otsuka Oncology Drugs Major Product Offerings
7.19.4 Otsuka Oncology Drugs Revenue in Global Market (2017-2022)
7.19.5 Otsuka Key News
7.20 Eisai
7.20.1 Eisai Corporate Summary
7.20.2 Eisai Business Overview
7.20.3 Eisai Oncology Drugs Major Product Offerings
7.20.4 Eisai Oncology Drugs Revenue in Global Market (2017-2022)
7.20.5 Eisai Key News
7.21 Merck KGaA
7.21.1 Merck KGaA Corporate Summary
7.21.2 Merck KGaA Business Overview
7.21.3 Merck KGaA Oncology Drugs Major Product Offerings
7.21.4 Merck KGaA Oncology Drugs Revenue in Global Market (2017-2022)
7.21.5 Merck KGaA Key News
7.22 Gilead Sciences
7.22.1 Gilead Sciences Corporate Summary
7.22.2 Gilead Sciences Business Overview
7.22.3 Gilead Sciences Oncology Drugs Major Product Offerings
7.22.4 Gilead Sciences Oncology Drugs Revenue in Global Market (2017-2022)
7.22.5 Gilead Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Oncology Drugs Market Opportunities & Trends in Global Market
Table 2. Oncology Drugs Market Drivers in Global Market
Table 3. Oncology Drugs Market Restraints in Global Market
Table 4. Key Players of Oncology Drugs in Global Market
Table 5. Top Oncology Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oncology Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oncology Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oncology Drugs Product Type
Table 9. List of Global Tier 1 Oncology Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Oncology Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oncology Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oncology Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Oncology Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oncology Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oncology Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Oncology Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oncology Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oncology Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oncology Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oncology Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oncology Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oncology Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oncology Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oncology Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oncology Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oncology Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oncology Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oncology Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Oncology Drugs Product Offerings
Table 32. Roche Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Oncology Drugs Product Offerings
Table 35. Celgene Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Oncology Drugs Product Offerings
Table 38. Novartis Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Oncology Drugs Product Offerings
Table 41. Bristol-Myers Squibb Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Oncology Drugs Product Offerings
Table 44. Johnson & Johnson Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Merck & Co. Corporate Summary
Table 46. Merck & Co. Oncology Drugs Product Offerings
Table 47. Merck & Co. Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Oncology Drugs Product Offerings
Table 50. AstraZeneca Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Oncology Drugs Product Offerings
Table 53. Pfizer Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Corporate Summary
Table 55. Amgen Oncology Drugs Product Offerings
Table 56. Amgen Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Eli Lilly Corporate Summary
Table 58. Eli Lilly Oncology Drugs Product Offerings
Table 59. Eli Lilly Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 60. AbbVie Corporate Summary
Table 61. AbbVie Oncology Drugs Product Offerings
Table 62. AbbVie Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Takeda Corporate Summary
Table 64. Takeda Oncology Drugs Product Offerings
Table 65. Takeda Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Astellas Corporate Summary
Table 67. Astellas Oncology Drugs Product Offerings
Table 68. Astellas Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Ipsen Corporate Summary
Table 70. Ipsen Oncology Drugs Product Offerings
Table 71. Ipsen Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Sanofi Corporate Summary
Table 73. Sanofi Oncology Drugs Product Offerings
Table 74. Sanofi Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Bayer Corporate Summary
Table 76. Bayer Oncology Drugs Product Offerings
Table 77. Bayer Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Biogen Idec Corporate Summary
Table 79. Biogen Idec Oncology Drugs Product Offerings
Table 80. Biogen Idec Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 81. Teva Corporate Summary
Table 82. Teva Oncology Drugs Product Offerings
Table 83. Teva Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 84. Otsuka Corporate Summary
Table 85. Otsuka Oncology Drugs Product Offerings
Table 86. Otsuka Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 87. Eisai Corporate Summary
Table 88. Eisai Oncology Drugs Product Offerings
Table 89. Eisai Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 90. Merck KGaA Corporate Summary
Table 91. Merck KGaA Oncology Drugs Product Offerings
Table 92. Merck KGaA Oncology Drugs Revenue (US$, Mn), (2017-2022)
Table 93. Gilead Sciences Corporate Summary
Table 94. Gilead Sciences Oncology Drugs Product Offerings
Table 95. Gilead Sciences Oncology Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Oncology Drugs Segment by Type in 2021
Figure 2. Oncology Drugs Segment by Application in 2021
Figure 3. Global Oncology Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oncology Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oncology Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Drugs Revenue in 2021
Figure 8. By Type - Global Oncology Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oncology Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oncology Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oncology Drugs Revenue Market Share, 2017-2028
Figure 12. US Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oncology Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oncology Drugs Revenue Market Share, 2017-2028
Figure 24. China Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oncology Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oncology Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oncology Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck & Co. Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli Lilly Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AbbVie Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Takeda Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Astellas Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Ipsen Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Sanofi Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Bayer Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Biogen Idec Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Teva Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Otsuka Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Eisai Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Merck KGaA Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Gilead Sciences Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global 5-Fluorouracil Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 76
The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.
North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
Global Carboplatin Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
Global Neutropenia Drugs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 96
The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
Global Small Molecule Cancer Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
Global Capecitabine Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 80
Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
Global Oxaliplatin Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.
In this report, only The finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
Global Cancer Treatment Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
Global Capecitabine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period.
The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Methotrexate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
